Order Article Reprints

Galíndez-Agirregoikoa E, Prieto-Peña D, García-Vivar ML, Belzunegui Otano JM, Joven-Ibáñez B, Vergara-Dangond C, Pavía-Pascual M, Urionaguena-Onaindia I, Vega Alvarez L, Puche Larrubia MÁ, et al. Treatment with Upadacitinib in Difficult-to-Treat (D2T) Psoriatic Arthritis (PsA): A National Multicenter Study of the First 134 Patients in Clinical Practice. Sci. 2025; 7(2):67. https://doi.org/10.3390/sci7020067

Galíndez-Agirregoikoa, Eva, Diana Prieto-Peña, Maria Luz García-Vivar, Joaquin Maria Belzunegui Otano, Beatriz Joven-Ibáñez, Cristina Vergara-Dangond, Marina Pavía-Pascual, Irati Urionaguena-Onaindia, Lucia Vega Alvarez, M. Ángeles Puche Larrubia, and et al. 2025. "Treatment with Upadacitinib in Difficult-to-Treat (D2T) Psoriatic Arthritis (PsA): A National Multicenter Study of the First 134 Patients in Clinical Practice" Sci 7, no. 2: 67. https://doi.org/10.3390/sci7020067

Galíndez-Agirregoikoa, E., Prieto-Peña, D., García-Vivar, M. L., Belzunegui Otano, J. M., Joven-Ibáñez, B., Vergara-Dangond, C., Pavía-Pascual, M., Urionaguena-Onaindia, I., Vega Alvarez, L., Puche Larrubia, M. Á., Ramos Giráldez, C., Garcia-Vicuña, R., Jovani, V., Martínez-Ferrer, A., Moreno Martínez-Losa, M., González Hernández, T., Almodóvar González, R., Urruticoechea-Arana, A., Macía-Villa, C., ... Upadacitinib PsA Clinical Practice COLLABORATIVE STUDY GROUP. (2025). Treatment with Upadacitinib in Difficult-to-Treat (D2T) Psoriatic Arthritis (PsA): A National Multicenter Study of the First 134 Patients in Clinical Practice. Sci, 7(2), 67. https://doi.org/10.3390/sci7020067